# Simultaneous epigenomic profiling and regulatory activity measurement using e2MPRA

**Authors:** Zicong Zhang, Ilias Georgakopoulos-Soares, Guillaume Bourque, Nadav Ahituv, Fumitaka Inoue

PMC · DOI: 10.1038/s41467-026-68422-3 · Nature Communications · 2026-01-14

## TL;DR

e2MPRA is a new method that measures both gene regulation and epigenetic changes in the same DNA sequences, helping understand how genetic variations affect traits and disease.

## Contribution

e2MPRA is the first technology to simultaneously analyze regulatory function and epigenomic modifications of specific DNA sequences.

## Key findings

- e2MPRA enables simultaneous analysis of regulatory activity and epigenetic modifications of cis-regulatory elements.
- The method can dissect the epigenetic functions of transcription factor motifs in synthetic enhancers.
- e2MPRA evaluates the effects of sequence perturbations on epigenetic states and regulatory function.

## Abstract

Using various biochemical assays that identify transcription factor (TF) binding and histone modifications, cis-regulatory elements (CREs) can be annotated in a genome-wide manner. However, these assays are descriptive and require functional validation. To the best of our knowledge, no technology can simultaneously analyze the regulatory function and epigenomic modifications of a specific sequence. Here, we develop an enrichment followed by epigenomic profiling massively parallel reporter assay (e2MPRA). This technique uses lentivirus to enrich for the integration of specific CREs into the genome and applies MPRA, Cut&Tag or ATAC-seq on them enabling simultaneous, high-throughput analysis of regulatory activity, protein binding, and epigenetic modification. We demonstrate that e2MPRA can dissect the epigenetic functions of TF motifs arranged within synthetic enhancers and evaluate the effects of sequence perturbation on epigenetic states. In summary, e2MPRA advances our understanding of the regulatory code, its effect on the epigenome and how its alteration leads to phenotypic effects.

Changes in gene regulation are a major driver of human traits and disease. Here, authors develop e2MPRA, a high-throughput technology that simultaneously measures enhancer activity and associated epigenetic modifications, revealing how sequence variants influence regulatory function.

## Linked entities

- **Proteins:** SEP2 (K-box region and MADS-box transcription factor family protein)

## Full-text entities

- **Genes:** KDM1A (lysine demethylase 1A) [NCBI Gene 23028] {aka AIMAH3, AOF2, BHC110, CPRF, KDM1, LSD1}, EP300 (EP300 lysine acetyltransferase) [NCBI Gene 2033] {aka KAT3B, MKHK2, RSTS2, p300}, REST (RE1 silencing transcription factor) [NCBI Gene 5978] {aka DFNA27, GINGF5, HGF5, NRSF, WT6, XBR}, CEBPA (CCAAT enhancer binding protein alpha) [NCBI Gene 1050] {aka C/EBP-alpha, CEBP}, SOX2 (SRY-box transcription factor 2) [NCBI Gene 6657] {aka ANOP3, MCOPS3}, XBP1 (X-box binding protein 1) [NCBI Gene 7494] {aka TREB-5, TREB5, XBP-1, XBP2}, FOXK1 (forkhead box K1) [NCBI Gene 221937] {aka FOXK1L}, FOXA1 (forkhead box A1) [NCBI Gene 3169] {aka HNF3A, TCF3A}, PAQR7 (progestin and adipoQ receptor family member 7) [NCBI Gene 164091] {aka MPRA, PGLP, mSR}, POU5F1 (POU class 5 homeobox 1) [NCBI Gene 5460] {aka OCT3, OCT4, OCT4Borf1, OTF-3, OTF3, OTF4}, CRIPTOP4 (CRIPTO pseudogene 4) [NCBI Gene 22815] {aka CR-4, CRIPTO-4, TDGF1P4, TDGF4}, ONECUT1 (one cut homeobox 1) [NCBI Gene 3175] {aka HNF-6, HNF6, HNF6A}, NANOG (Nanog homeobox) [NCBI Gene 79923], PPARA (peroxisome proliferator activated receptor alpha) [NCBI Gene 5465] {aka NR1C1, PPAR, PPAR-alpha, PPARalpha, hPPAR}, F3 (coagulation factor III, tissue factor) [NCBI Gene 2152] {aka CD142, TF, TFA}, HNF1A (HNF1 homeobox A) [NCBI Gene 6927] {aka HNF-1-alpha, HNF-1A, HNF1, HNF1alpha, IDDM20, LFB1}, YY1 (YY1 transcription factor) [NCBI Gene 7528] {aka DELTA, GADEVS, INO80S, NF-E1, UCRBP, YIN-YANG-1}, CTCF (CCCTC-binding factor) [NCBI Gene 10664] {aka CFAP108, FAP108, MRD21}, LIPC (lipase C, hepatic type) [NCBI Gene 3990] {aka HDLCQ12, HL, HTGL}, EHMT1 (euchromatic histone lysine methyltransferase 1) [NCBI Gene 79813] {aka EHMT1-IT1, EUHMTASE1, Eu-HMTase1, FP13812, GLP, GLP1}, XCL1 (X-C motif chemokine ligand 1) [NCBI Gene 6375] {aka ATAC, LPTN, LTN, SCM-1, SCM-1a, SCM1}, BANF1 (barrier to autointegration nuclear assembly factor 1) [NCBI Gene 8815] {aka BAF, BCRP1, D14S1460, NGPS}, NR2F2 (nuclear receptor subfamily 2 group F member 2) [NCBI Gene 7026] {aka ARP-1, ARP1, CHTD4, COUPTF2, COUPTFB, COUPTFII}, LGR5 (leucine rich repeat containing G protein-coupled receptor 5) [NCBI Gene 8549] {aka FEX, GPR49, GPR67, GRP49, HG38}, EHMT2 (euchromatic histone lysine methyltransferase 2) [NCBI Gene 10919] {aka BAT8, C6orf30, G9A, GAT8, KMT1C, NG36}
- **Diseases:** ENCODE (MESH:C564021), infection (MESH:D007239)
- **Chemicals:** agar (MESH:D000362), EDTA (MESH:D004492), ethanol (MESH:D000431), SDS (MESH:D012967), carbenicillin (MESH:D002228), phenol (MESH:D019800), Lentiviral (-), PBS (MESH:D007854), Polybrene (MESH:D006583), chloroform (MESH:D002725)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Lentivirus (genus) [taxon 11646], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** HEK293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), HepG2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027), CRL-3216 — Homo sapiens (Human), Turner syndrome, Transformed cell line (CVCL_9M67), H2K27ac — Mus musculus (Mouse), Hybridoma (CVCL_XK29), WTC11 — Homo sapiens (Human), Induced pluripotent stem cell (CVCL_Y803), HB-8065 — Homo sapiens (Human), Conditionally immortalized cell line (CVCL_J982)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12913623/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12913623/full.md

## References

11 references — full list in the complete paper: https://tomesphere.com/paper/PMC12913623/full.md

---
Source: https://tomesphere.com/paper/PMC12913623